Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > $tltff The FDA wants an option that has rates better then

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Apr 12, 2022 4:59pm

158 Views

Post# 34598314

RE:RE:RE:$tltff The FDA wants an option that has rates better then

Thanks Enrique,

That is great news. Glad you spoke to Dr. Mandel. I agree we should be pretty solid CR %s at 90 day. And, bcuz of the second treatment at 180 day, the 360day should also be solid. Maybe converting some PRs to CRs.... It is that 450 day mark that will be interesting? Should still be solid numbers then too, I'm guessing. :-)

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario